Laddar...
HER2 insertion YVMA mutant lung cancer: long natural history and response to afatinib
Human epidermal growth factor 2 (HER2, ERBB2) mutations in lung cancers are oncogenic drivers that respond to HER2 targeted therapies. Little is known about the sensitivity of subtypes of HER2 mutant lung cancers to targeted agents. We present a patient with HER2 mutant lung cancer with a 12 base pa...
Sparad:
| I publikationen: | Lung Cancer |
|---|---|
| Huvudupphovsmän: | , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4724317/ https://ncbi.nlm.nih.gov/pubmed/26559459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2015.10.025 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|